Business ❯ Finance ❯ Market Analysis ❯ Analyst Ratings

Goldman Sachs

Goldman Backs Apple as UBS Stays Neutral Before Jan. 29 Earnings

Pre‑earnings positioning hinges on iPhone momentum against rising component costs.

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

NuScale Shares Fall After Q3 Miss as Goldman Cuts Target

Baird Lifts Tesla to Outperform With Street-High $548 Target as Focus Turns to Autonomy